Search PubMed⌕ Search

PubMed · 9514071

Whither the global population problem.

Abstract

Growth of the human population has been underway for thousands of years and was never a problem until recently. It is now expanding exponentially, and today global population stands at nearly 6 billion with 97 million being added each year. Currently, overpopulation has led to serious social and environmental problems such as poverty, overcrowded slums, crime, terrorism, pollution of air and water, and depletion of the protective ozone layer. Warnings were sounded, but few listened. The enthusiasm once generated for solving the problem of too many people was short-lived. The press with puzzling abrogation of its responsibility to the public managed to allay all fears of population overgrowth. Two U.S. presidents welcomed such growth as a stimulus to economic development. Although modern contraceptives are safe, effective, and widely available, more are badly needed, but none are in the pipeline. Research is being hampered by hostile attitudes and by the high cost in time and money of bringing a new contraceptive to an uncertain market with the added threat of litigation. At the present rate of growth, the population will double in the next century. This is believed to be beyond the carrying capacity of our planet. Corrective measures by man or nature need to be undertaken.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R O Greep. 1998-02-15. Whither the global population problem.. https://doi.org/10.1016/s0006-2952(97)00319-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry.

This is the second report on the continuing efforts of LAGID to increase the recognition and registration of patients with primary immunodeficiency diseases in 12 Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Honduras, Mexico, Panama, Paraguay, Peru, Uruguay, and Venezuela. This report reveals that from a total of 3321 patients registered, the most common form of primary immunodeficiency disease was predominantly antibody deficiency (53.2%) with IgA deficiency reported as the most frequent phenotype. This category was followed by 22.6% other well-defined ID syndromes, 9.5% combined T- and B-cell inmunodeficiency, 8.6% phagocytic disorders, 3.3% diseases of immune dysregulation, and 2.8% complement deficiencies. All countries that participated in the first publication in 1998 reported an increase in registered primary immunodeficiency cases, ranging between 10 and 80%. A comparison of the estimated minimal incidence of X-linked agammaglobulinemia, chronic granulomatous disease, and severe combined immunodeficiency between the first report and the present one shows an increase in the reporting of these diseases in all countries. In this report, the estimated minimal incidence of chronic granulomatous disease was between 0.72 and 1.26 cases per 100,000 births in Argentina, Chile, Costa Rica, and Uruguay and the incidence of severe combined immunodeficiency was 1.28 and 3.79 per 100,000 births in Chile and Costa Rica, respectively. However, these diseases are underreported in other participating countries. In addition to a better diagnosis of primary immunodeficiency diseases, more work on improving the registration of patients by each participating country and by countries that have not yet joined LAGID is still needed.

Birth Rate↗